Ipamorelin 5mg

Ipamorelin is a selective growth hormone secretagogue (GHSR-1a agonist) used in controlled in-vitro studies to investigate receptor signalling, second-messenger dynamics, and GH-axis pathway modelling under non-clinical laboratory conditions.

Ipamorelin

This pentapeptide secretagogue is commonly selected to explore ligand–receptor engagement, cAMP/PKA and PLC/IP₃/Ca²⁺ readouts, and structure–activity relationships in cell systems.
For laboratory research only. Not for human use.

Ipamorelin Key features

• Selectively targets the ghrelin/secretagogue receptor (GHSR-1a) for in-vitro pharmacology studies.
• Supplied as a lyophilised solid for stability and straightforward storage.
• Unit size: 5 mg per vial.
• Each batch released only after stringent quality checks.

Specifications

• Product name: Ipamorelin
• Synonyms: GHSR agonist; growth hormone secretagogue
• Sequence (reference): Aib–His–D-2-Nal–D-Phe–Lys–NH₂
  (Aib = 2-aminoisobutyric acid; 2-Nal = 3-(2-naphthyl)-D-alanine)
• Class: Pentapeptide secretagogue (ghrelin/secretagogue receptor agonist)
• Form: Lyophilised powder
• Appearance: White to off-white solid
• Note: Counter-ion/hydration state may vary.

Handling & storage

1. Storage (dry): Keep vials protected from light and moisture.
2. Reconstitution: Bring vial and diluent to room temperature. Reconstitute with
   Bacteriostatic Water 10 ml. Swirl gently — do not vortex.
3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Looking for complementary materials? See
Bacteriostatic Water 10 ml and GH-axis research companions such as
CJC-1295 (No DAC) 5 mg and
GHRP-6 5 mg.

About ipamorelin in research

Researchers employ ipamorelin to map GHSR-1a binding characteristics, profile downstream second-messenger responses, and compare potency/selectivity against other secretagogues in cell-based assays. Work focuses on receptor pharmacology and pathway profiling exclusively in controlled, non-clinical in-vitro environments.